Intrinsic Value Partners, LLC Moderna, Inc. Transaction History
Intrinsic Value Partners, LLC
- $95.7 Million
- Q3 2024
A detailed history of Intrinsic Value Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Intrinsic Value Partners, LLC holds 51,392 shares of MRNA stock, worth $2.11 Million. This represents 3.59% of its overall portfolio holdings.
Number of Shares
51,392
Previous 26,887
91.14%
Holding current value
$2.11 Million
Previous $3.19 Million
7.58%
% of portfolio
3.59%
Previous 3.45%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.75 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.65 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.05 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$693 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$297 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...